Additional file 3 of Serum soluble CD26/DPP4 titer variation is a potential prognostic biomarker in cancer therapy with a humanized anti-CD26 antibody

Authors :: Kaneko, Yutaro
Hatano, Ryo
Hirota, Naoto
Isambert, Nicolas
Trillet-Lenoir, Véronique
Benoit You
Alexandre, Jérôme
Zalcman, Gérard
Valleix, Fanny
Podoll, Thomas
Umezawa, Yoshimi
Takao, Seiichi
Iwata, Satoshi
Hosono, Osamu
Taguchi, Tetsuo
Taketo Yamada
Dang, Nam H.
Ohnuma, Kei
Angevin, Eric
Morimoto, Chikao
Publication Year :: 2021
Publisher :: figshare, 2021.
Abstract: Additional file 3: Figure S1. Correlation between serum soluble CD26 level and DPP4 enzyme activity

Full Text Access

Tools